MB, Levis & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Hold
35
﹤0.01% 171
2026
Q1
$11.5K Hold
35
﹤0.01% 158
2025
Q4
$12.3K Hold
35
0.01% 157
2025
Q3
$12.9K Hold
35
0.01% 155
2025
Q2
$13.8K Sell
35
-8
-19% -$2.99K 0.01% 180
2025
Q1
$16K Hold
43
0.01% 170
2024
Q4
$15.5K Sell
43
-13
-23% -$4.82K 0.01% 169
2024
Q3
$20.2K Hold
56
0.01% 161
2024
Q2
$19.1K Sell
56
-12
-18% -$4.07K 0.01% 159
2024
Q1
$24.3K Hold
68
0.01% 149
2023
Q4
$20.4K Hold
68
0.01% 154
2023
Q3
$18.6K Hold
68
0.01% 162
2023
Q2
$20.7K Hold
68
0.01% 156
2023
Q1
$19.4K Hold
68
0.01% 159
2022
Q4
$16.6K Buy
+68
New +$15.4K 0.01% 160

Other funds holding SYK

MB, Levis & Associates's SYK Position: Q2 2026 in Review

MB, Levis & Associates held its Stryker (SYK) position steady in Q2 2026 at 35 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #171.

MB, Levis & Associates first reported a position in SYK in Q4 2022 and has held it in 15 quarters since. The position peaked at $24.3K in Q1 2024. 720 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • MB, Levis & Associates held 35 shares of Stryker worth $11K as of Q2 2026.
  • MB, Levis & Associates left its Stryker share count unchanged in Q2 2026.
  • Stryker made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #171 holding.
  • MB, Levis & Associates first reported a position in Stryker in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Stryker position peaked at $24.3K in Q1 2024.
  • 720 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.